What We're Reading: Page 292
Industry reads hand-picked by our editors
Sep 19, 2017
Sep 18, 2017
Sep 15, 2017
Sep 14, 2017
-
Healthcare Dive
Senators offer polar opposite plans for changing healthcare system
-
Bloomberg
Japan's push to cut drug costs risks U.S. trade friction
-
Xconomy
BridgeBio bags $135M for “hub and spoke” rare disease drug R&D
-
Chicago Tribune
Insurers cutting back on drug coupons, saying it keeps consumer costs down
Sep 13, 2017
Sep 12, 2017
-
The New York Times
Suicide data incorrectly reported in drug trials, suit claimed
-
Scientific American
Powerful childhood cancer treatment holds promise — and poses hazards
-
The Guardian
Pharmaceutical companies gave $12m to doctors, nurses and pharmacists
Sep 11, 2017
-
TechCrunch
23andMe’s second act sits squarely in drug research and development
-
The Washington Post
Tick saliva may be a secret ingredient to help HIV patients
-
Financial Times
Magic mushrooms take a trip into clinical trials
-
Business Insider
A biotech CEO who sold his last company for $14 billion explains why he wants to do things differently this time
Previous
